Improved adjuvant endocrine therapy for premenopausal women with endocrine responsive disease

Results from two randomised global trials (SOFT & TEXT) designed to newly define the most effective components of adjuvant endocrine therapy for premenopausal women with endocrine responsive disease, showed that for some, those with high risk of relapse, the use of the aromatase inhibitor exemes...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldhirsch, Aron, Colleoni, Marco, Regan, Meredith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2015
Materias:
Visions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462884/
https://www.ncbi.nlm.nih.gov/pubmed/26082801
http://dx.doi.org/10.3332/ecancer.2015.544

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462884/
https://www.ncbi.nlm.nih.gov/pubmed/26082801
http://dx.doi.org/10.3332/ecancer.2015.544

Ejemplares similares